60031-08-5

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
1-Indanone-6-carboxylic acid is utilized as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its ability to participate in multiple chemical reactions allows for the creation of a wide range of compounds with specific therapeutic or pesticidal properties.
Used in Material Science:
In the field of material science, 1-Indanone-6-carboxylic acid is employed for its potential to contribute to the development of new materials with unique properties. Its chemical versatility can be harnessed to engineer materials with tailored characteristics for specific applications.
Used in Research and Development:
1-Indanone-6-carboxylic acid serves as a valuable tool for researchers and chemists in the exploration of new compounds with diverse applications. Its potential biological activities, such as anti-inflammatory and anti-tumor effects, make it an interesting subject for studies aimed at discovering novel therapeutic agents or understanding underlying biological mechanisms.

InChI:InChI=1/C10H8O3/c11-9-4-3-6-1-2-7(10(12)13)5-8(6)9/h1-2,5H,3-4H2,(H,12,13)

Upstream product

• 866848-94-4 6‘-bromo-2‘,3‘-dihydrospiro[[1,3]dioxolane-2,1‘-indene] 
• 124-38-9 carbon dioxide 
• 38628-51-2 3-(4-carboxyphenyl)propionic acid 

Downstream Products

• 161688-83-1 1-benzyl-6-(α-hydroxybenzyl)indane 
• 161688-84-2 1-benzyl-6-(bromomethyl)indane 
• 145625-29-2 3-(1-benzylindan-6-yl)propionic acid 
• 145625-31-6 1-benzyl-6-isobutylindane 
• 146393-42-2 1-benzyl-6-formylindane 
• 68634-03-7 3-oxo-indan-5-carboxylic acid methyl ester 
• 146393-40-0 1-benzyl-6-(hydroxymethyl)indane 

Relevant academic research and scientific papers

Ratiometric O2 sensing based on selective self-sensitized photooxidation of donor-acceptor fluorophores

We report a series of organic fluorophores that undergo selective self-sensitized photooxidation upon light irradiation in air accompanied by a change of fluorescence from yellow to blue on the seconds timescale. The distinct emission changes allow the ratiometric quantitation of O2 concentration.

Substituted Benzamide Compounds

Substituted benzamide compounds corresponding to formula (I) in which R5, R6, R7, R8, a, b, c, d, t, D and X have defined meanings, a process for their preparation, pharmaceutical compositions comprising such compounds, and a method of using such compounds to treat pain and other conditions mediated at least in part via the bradykinin 1 receptor.

Substituted Spiro-amide Compounds

Substituted spiro-amide compounds corresponding to formula I in which R5 through R8, D, X, Y and Z have defined meanings, processes for preparing such spiro-amide compounds, pharmaceutical compositions containing such compounds, and methods of using such spiro-amide compounds for treating and/or inhibiting disorders or disease states mediated at least in part by the bradykinin 1 receptor.

TRICYCLIC PYRAZOLE KINASE INHIBITORS

Compounds of the present invention are useful for inhibiting protein tyrosine kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

NOVEL M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS

Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.

The design of dipeptide helical mimetics, Part I: The synthesis of 1,6-disubstituted indanes

The design and synthesis of conformationally restrained, non-peptide templates (1,6-disubstituted indanes) which allow the incorporation of two adjacent amino acid side-chains in an orientation similar to that found in alpha-helices is reported.